News & Events
-
October 24, 2016
Advancing Tuberculosis Drug Regimen Development through Innovative Quantitative Translational Pharmacology Methods and Approaches
Hanna D, Romero K, Schito M. Advancing Tuberculosis Drug Regimen Development through Innovative Quantitative Translational Pharmacology Methods and Approaches. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2016 Oct 24;56:208–11.
-
October 17, 2016
IMI SAFE-T and C-Path PSTC Obtain Regulatory Support for New Liver Safety Biomarkers
Oct 17, 2016 IMI SAFE-T and C-Path PSTC Obtain Regulatory Support for New Liver Safety Biomarkers US FDA and EMA Letters of Support Pave the Way for Clinical Qualification The Innovative Medicines Initiative (IMI) SAFE-T (Safer and Faster Evidence Based Translation) Consortium and Critical Path Institute (C-Path) Predictive Safety Testing Consortium (PSTC)... -
October 12, 2016
Coalition Against Major Diseases 2016 Annual Regulatory Science Workshop
October 12, 2016 College Park Marriott Hotel and Conference Center, Hyattsville, Maryland SPONSORED BY: Critical Path Institute MEETING MINUTES [PDF] (Presentations are linked in the agenda, below.) Overview and Objectives The Coalition Against Major Diseases (CAMD) is a public-private partnership aimed at developing creating Drug Development Tools that can be applied to increase... -
October 10, 2016
Critical Path for Parkinson’s Consortium achieves regulatory support in Europe for use of imaging biomarker in Parkinson’s disease clinical trials
Oct 10, 2016 Critical Path for Parkinson’s Consortium achieves regulatory support in Europe for use of imaging biomarker in Parkinson’s disease clinical trials London and Tucson, Ariz., October 10, 2016 — The Critical Path Institute (C-Path), in partnership with Parkinson’s UK, announced today that the European Medicines Agency (EMA) has issued a... -
October 1, 2016
Development of a symptom-based patient-reported outcome instrument for functional dyspepsia: A preliminary conceptual model and an evaluation of the adequacy of existing instruments
Taylor F, Reasner DS, Carson RT, Deal LS, Foley C, Iovin R, Lundy JJ, Pompilus F, Shields AL, Silberg DG. Development of a symptom-based patient-reported outcome instrument for functional dyspepsia: a preliminary conceptual model and an evaluation of the adequacy of existing instruments. The Patient – Patient-Centered Outcomes Research 2016;9(5):409-418.